CHO

A Protein Vaccine for COVID Immunity

Karen Simpson — Mon, 31 May 2021 19:11:29 +0000

June

2021

Researchers at the Scripps Research Institute are developing a protein vaccine candidate to combat new variants of SARS-CoV-2.

Novel Anion Exchange Media for Viral Clearance

Sonja Bradfield — Tue, 04 Sep 2018 18:23:04 +0000

Archived Webinar

Wednesday, September 26, 2018,

2:00pm to 3:00pm

EDT

The need for higher performance and lower cost manufacturing processes in biologic process development is intensifying.

Development of Next Generation Purification Platforms through Novel Technologies and Holistic Process Engineering Approaches

Idell Bryan — Tue, 10 Apr 2018 16:14:27 +0000

Archived Webinar

Wednesday, May 2, 2018,

2:00pm to 3:00pm

EDT

How can you address new requirements to shrink time to clinic and decrease biopharmaceutical manufacturing cost and risk? Take this webinar to find out. Join 3M’s, Alexei Voloshin, as he discusses...

Improvement of Cell-Freezing Technologies and Disposable Bioreactors: Toward a Fully Closed USP Process?

Site Administrator — Wed, 06 Nov 2013 15:40:00 +0000

Conference Presentation

AIChE Annual Meeting

November 6, 2013

Biotech processes still contain a number of open and at risk transfers steps. Cell culture steps from one frozen vial to containers such as T-flasks...

Recombinant Protein Therapeutics from CHO Cells -- 20 Years and Counting

Site Administrator — Fri, 04 May 2012 21:29:14 +0000

The CHO cell is at its height of technological prominence thanks to its adaptability to various culture conditions and plasticity in the context of genetic alterations. With further research, the application ofCell Culture Strategies based on...

October

2007

Deciphering the Mechanisms of Therapeutic Protein Production

Site Administrator — Fri, 04 May 2012 21:29:14 +0000

Demand for therapeutic recombinant proteins will eventually exceed current production capabilities. This is a major driver in further understanding Chinese Hamster Ovary (CHO) cell biology, which is the cell line of choice for producing these...

October

2007

Industry and SBE News

Site Administrator — Fri, 04 May 2012 21:29:14 +0000

Dr. George Georgiou to Receive SBE's James E. Bailey Award; Averting an Epidemic— Novel Device Detects Avian Flu Virus in Less than Half an Hour; Cell-Free Protein Sythesis Comes of Age; Genetically Engineering Microorganisms into Pharmaceutical...

October

2007

Towards Genome Engineering in Chinese Hamster Ovary Cells

Site Administrator — Tue, 07 Dec 2010 17:35:49 +0000

Archived Webinar

Tuesday, December 14, 2010, 2:00pm EST

Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations. Their importance in the health...

Singapore: An Emerging Leader in Biomedical Sciences

Site Administrator — Thu, 04 Oct 2007 21:29:14 +0000

With a heavy investment in biomedical research— particularly the $330 million to build Biopolis in 2003— Singapore is seeing the fruits of its labor blossom.

October

2007